Physician profile
Amanda E Ribbeck
NPI 1417214271
$9,514.08
in general payments reported to CMS, 2019-2025
43 companies · $3,121 in 2025
The $3,121 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $391 · 2021: $936 · 2022: $1,227 · 2023: $1,658 · 2024: $1,739 · 2025: $3,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,378 · Consulting Fee: $1,108 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,377.59 |
| Consulting Fee | $1,108.00 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $1,499.12 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $533.91 | 2019-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $493.65 | 2022-2025 | Onpattro |
| Novartis Pharmaceuticals Corporation | $479.68 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $477.34 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $410.96 | 2019-2025 | Jardiance |
| Edwards Lifesciences Corporation | $390.97 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biotronik INC. | $387.25 | 2022-2025 | Acticor 7 Vr-T Dx |
| Abbott Laboratories | $333.99 | 2019-2025 | Jot Dx, Mitraclip, Amplatzer Amulet |
| Amgen INC. | $331.40 | 2019-2024 | Repatha |
| Pfizer INC. | $329.27 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $289.07 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $264.82 | 2021-2025 | Verquvo |
| Astellas Pharma US INC | $262.31 | 2019-2023 | Lexiscan |
| Boston Scientific Corporation | $252.21 | 2020-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $224.64 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $218.67 | 2021-2025 | Evkeeza |
| Amarin Pharma, INC. | $216.79 | 2019-2023 | |
| Novo Nordisk INC | $209.15 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $207.69 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $197.18 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.15 | 2021-2025 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $155.33 | 2022-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $152.81 | 2022-2025 | Assure Wcd |
| Scpharmaceuticals INC. | $144.78 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $105.46 | 2023-2024 | Optimizer, Optimizer |
| Lexicon Pharmaceuticals, INC. | $92.90 | 2023-2024 | Inpefa |
| Medtronic, INC. | $87.54 | 2021-2024 | Symplicity G3, Venaseal |
| Abiomed | $85.89 | 2024-2025 | Impella |
| Recor Medical INC | $68.96 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Cvrx, INC. | $68.11 | 2024-2025 | Barostim Neo System |
| Irhythm Technologies, INC. | $60.57 | 2022-2023 | Zio Xt Patch |
| Baxter Healthcare | $58.09 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Daiichi Sankyo INC. | $52.67 | 2019-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $40.31 | 2025 | |
| Corcept Therapeutics | $30.46 | 2025 | Korlym |
| Inspire Medical Systems, INC. | $23.81 | 2024 | Inspire |
| Tactile Systems Technology INC | $23.68 | 2023 | Entre Plus, Flexitouch Plus |
| Heartflow, INC. | $22.29 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $20.19 | 2024 | Uptravi, Opsumit |
| Lundbeck LLC | $14.81 | 2019 | |
| Gilead Sciences, INC. | $14.78 | 2019 | |
| Medtronic Vascular, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Ribbeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.